Free equity investment tool of Japanese companies

Financial Statement Details

Annual

First quarter

Second quarter

Third quarter

Sponsored Link

Related Company

HISAMITSU PHARMACEUTICAL

Shin-Etsu Chemical

Fuso Pharmaceutical Industries

ROHTO PHARMACEUTICAL

ADEKA

塩野義製薬

富士製薬工業

アステラス製薬

エスケー化研

中外製薬

関西ペイント

Mitsubishi Tanabe Pharma

JSR

Kao

DAIICHI SANKYO

EDIUNET Related Ranking

EDIUNET

EDIUNET Credit Rating

EDIUNET Industry Avg

EDIUNET Prefectures

Yuho! Industry

EDIUNET Rating News

Prev « 2024-04 » Next

Mon	Tue	Wed	Thu	Fri	Sat	Sun
1 -	2 -	3 -	4 -	5 -	6 -	7 -
8 -	9 -	10 -	11 -	12 -	13 -	14 -
15 -	16 -	17 -	18 -	19 -	20 -	21 -
22 -	23 -	24 -	25 -	26 -	27 -	28 -
29 -	30 -

[Update list]

1/28 Retail Trade (CAWACHI:A etc...

1/27 Banks (The Awa Bank:BBB→A)

1/23 Chemicals (Milbon:AA→AAA)

1/21 Glass & Ceramics Products (..

1/21 Machinery (TSUDAKOMA:C)

1/21 Other Services (Netindex.:CC)

1/20 Other Products (Kurogane Kos..

1/20 Wholesale Trade (リーバイ・..

1/20 Other Services (川崎地質:BB→..

1/17 Chemicals (Kawaguchi Chemica..

 RSS

 Company RSS

 Daily RSS

Sponsored Link

Recently Download Chart

NIPPON COKE & ENGINEERING

NITCHITSU　

Yushiro Chemical Indutry

クラリオン

クラリオン

Financial Statement Details: HISAMITSU PHARMACEUTICAL (Annual )

Two or more periods are displayed by each of subject collectively.Two or more companies can be compared and financial statement data can also be downloaded.

【Analysis Menu】 Outline Statement Rating Indicator Download

Sponsored Link

*Free Download Financial Statement data

F/S Outline: HISAMITSU PHARMACEUTICAL (Annual )

Switch ViewU-ChartU-Chart and F/SF/S

Consolidated :Balance sheet (B/S) Consolidated | Non-Consolidated | Small | Large
U-Chart(pie chart)	2010-02-28	2011-02-28	2012-02-29	2013-02-28
Cash etc. Other Current Assets Tangible Assets Intangible Assets Investment etc. Current Liabilities Fixed Liabilities Capital stock Capital surplus etc.	*IN(*Right half), OUT(*Left half), BALANCE(*Net Assets)
	[BS] 2010-02-28  *  Total: ¥ 193 B  *  Net: ¥ 130 B  (Ratio: 67.67%)	[BS] 2011-02-28  *  Total: ¥ 194 B  *  Net: ¥ 141 B  (Ratio: 72.50%)	[BS] 2012-02-29  *  Total: ¥ 192 B  *  Net: ¥ 149 B  (Ratio: 77.40%)	[BS] 2013-02-28  *  Total: ¥ 214 B  *  Net: ¥ 167 B  (Ratio: 78.42%)
Financial Statement Details	2010-02-28	2011-02-28	2012-02-29	2013-02-28
Cash etc.	¥ 26 B	¥ 33 B	¥ 27 B	¥ 41 B
Other Current Assets	¥ 59 B	¥ 59 B	¥ 59 B	¥ 66 B
Tangible Assets	¥ 46 B	¥ 44 B	¥ 43 B	¥ 43 B
Intangible Assets	¥ 15 B	¥ 12 B	¥ 16 B	¥ 17 B
Investment etc.	¥ 45 B	¥ 44 B	¥ 45 B	¥ 46 B
Total Assets	¥ 193 B	¥ 194 B	¥ 192 B	¥ 214 B
Current Liabilities	¥ 42 B	¥ 39 B	¥ 31 B	¥ 34 B
Fixed Liabilities	¥ 19 B	¥ 14 B	¥ 12 B	¥ 11 B
Capital stock	¥ 8 B	¥ 8 B	¥ 8 B	¥ 8 B
Capital surplus etc.	¥ 122 B	¥ 132 B	¥ 140 B	¥ 159 B
Liabilities and net assets	¥ 193 B	¥ 194 B	¥ 192 B	¥ 214 B
Consolidated :Income statement (P/L) Consolidated | Non-Consolidated | Small | Large
U-Chart(pie chart)	2010-02-28	2011-02-28	2012-02-29	2013-02-28
Sales Cost of Sales Other income SG&A Other expenses Net income	*IN(*Right half), OUT(*Left half), BALANCE(*Net Income)
	[PL] 2010-02-28  *  Sales: ¥ 129 B  *  Income: ¥ 18 B  (Ratio: 14.19%)	[PL] 2011-02-28  *  Sales: ¥ 137 B  *  Income: ¥ 20 B  (Ratio: 15.28%)	[PL] 2012-02-29  *  Sales: ¥ 137 B  *  Income: ¥ 18 B  (Ratio: 13.38%)	[PL] 2013-02-28  *  Sales: ¥ 142 B  *  Income: ¥ 18 B  (Ratio: 13.17%)
Financial Statement Details	2010-02-28	2011-02-28	2012-02-29	2013-02-28
Sales	¥ 129 B	¥ 137 B	¥ 137 B	¥ 142 B
Cost of Sales	¥ 42 B	¥ 47 B	¥ 46 B	¥ 51 B
Gross profit	¥ 87 B	¥ 89 B	¥ 91 B	¥ 91 B
Other income	¥ 4 B	¥ 8 B	¥ 16 B	¥ 8 B
SG&A	¥ 58 B	¥ 61 B	¥ 65 B	¥ 65 B
Other expenses	¥ 14 B	¥ 15 B	¥ 23 B	¥ 15 B
Net income	¥ 18 B	¥ 20 B	¥ 18 B	¥ 18 B
Consolidated :Cash flow statement (C/F) Consolidated | Non-Consolidated | Small | Large
U-Chart(pie chart)	2010-02-28	2011-02-28	2012-02-29	2013-02-28
Operating CF Investment CF Financial CF Foreign Exchange Effects Net Change in Cash	*IN(*Right half), OUT(*Left half), BALANCE(*Net Change in Cash)
	[CF] 2010-02-28  *  OCF: ¥ 20 B  *  Cash: ¥ -7 B	[CF] 2011-02-28  *  OCF: ¥ 36 B  *  Cash: ¥ +11 B	[CF] 2012-02-29  *  OCF: ¥ 25 B  *  Cash: ¥ -3 B	[CF] 2013-02-28  *  OCF: ¥ 32 B  *  Cash: ¥ +16 B
Financial Statement Details	2010-02-28	2011-02-28	2012-02-29	2013-02-28
Operating CF	¥ 20 B	¥ 36 B	¥ 25 B	¥ 32 B
Investment CF	¥ -32 B	¥ -8 B	¥ -15 B	¥ -7 B
Financial CF	¥ 4 B	¥ -15 B	¥ -13 B	¥ -9 B
Foreign Exchange Effects	¥ 25 M	¥ -1 B	¥ -506 M	¥ 1 B
Net Change in Cash	¥ -7 B	¥ 11 B	¥ -3 B	¥ 16 B
Consolidated :Shareowners' equity (S/S) Consolidated | Non-Consolidated | Small | Large
U-Chart(pie chart)	2010-02-28	2011-02-28	2012-02-29	2013-02-28
Issuance of new shares Dividends from surplus Net income Purchase of treasury stock Other Change in Stockholders Equity Other Change in Net Assets Net Change in Net Assets	*IN(*Right half), OUT(*Left half), BALANCE(*Net Change in Net Assets)
	[SS] 2010-02-28  *  Income: ¥ 18 B  *  Net: ¥ +6 B	[SS] 2011-02-28  *  Income: ¥ 20 B  *  Net: ¥ +10 B	[SS] 2012-02-29  *  Income: ¥ 18 B  *  Net: ¥ +8 B	[SS] 2013-02-28  *  Income: ¥ 18 B  *  Net: ¥ +18 B
Financial Statement Details	2010-02-28	2011-02-28	2012-02-29	2013-02-28
Issuance of new shares	-	-	-	-
Dividends from surplus	¥ -5 B	¥ -5 B	¥ -6 B	¥ -5 B
Net income	¥ 18 B	¥ 20 B	¥ 18 B	¥ 18 B
Purchase of treasury stock	¥ -5 B	¥ -4 M	¥ -3 B	¥ -1 M
Other Change in Stockholders Equity	-	¥ -1 M	¥ -2 M	¥ -1 M
Other Change in Net Assets	¥ 171 M	¥ -4 B	¥ -1 B	¥ 5 B
Net Change in Net Assets	¥ 6 B	¥ 10 B	¥ 8 B	¥ 18 B

Non-Consolidated :Balance sheet (B/S) Consolidated | Non-Consolidated | Small | Large
U-Chart(pie chart)	2010-02-28	2011-02-28	2012-02-29	2013-02-28
Cash etc. Other Current Assets Tangible Assets Intangible Assets Investment etc. Current Liabilities Fixed Liabilities Capital stock Capital surplus etc.	*IN(*Right half), OUT(*Left half), BALANCE(*Net Assets)
	[BS] 2010-02-28  *  Total: ¥ 180 B  *  Net: ¥ 130 B  (Ratio: 72.36%)	[BS] 2011-02-28  *  Total: ¥ 187 B  *  Net: ¥ 145 B  (Ratio: 77.64%)	[BS] 2012-02-29  *  Total: ¥ 184 B  *  Net: ¥ 153 B  (Ratio: 83.34%)	[BS] 2013-02-28  *  Total: ¥ 200 B  *  Net: ¥ 168 B  (Ratio: 83.96%)
Financial Statement Details	2010-02-28	2011-02-28	2012-02-29	2013-02-28
Cash etc.	¥ 17 B	¥ 24 B	¥ 20 B	¥ 34 B
Other Current Assets	¥ 51 B	¥ 49 B	¥ 46 B	¥ 47 B
Tangible Assets	¥ 35 B	¥ 33 B	¥ 30 B	¥ 30 B
Intangible Assets	¥ 2 B	¥ 2 B	¥ 7 B	¥ 6 B
Investment etc.	¥ 73 B	¥ 77 B	¥ 78 B	¥ 81 B
Total Assets	¥ 180 B	¥ 187 B	¥ 184 B	¥ 200 B
Current Liabilities	¥ 34 B	¥ 31 B	¥ 22 B	¥ 24 B
Fixed Liabilities	¥ 15 B	¥ 10 B	¥ 7 B	¥ 8 B
Capital stock	¥ 8 B	¥ 8 B	¥ 8 B	¥ 8 B
Capital surplus etc.	¥ 122 B	¥ 137 B	¥ 145 B	¥ 159 B
Liabilities and net assets	¥ 180 B	¥ 187 B	¥ 184 B	¥ 200 B
Non-Consolidated :Income statement (P/L) Consolidated | Non-Consolidated | Small | Large
U-Chart(pie chart)	2010-02-28	2011-02-28	2012-02-29	2013-02-28
Sales Cost of Sales Other income SG&A Other expenses Net income	*IN(*Right half), OUT(*Left half), BALANCE(*Net Income)
	[PL] 2010-02-28  *  Sales: ¥ 120 B  *  Income: ¥ 20 B  (Ratio: 16.59%)	[PL] 2011-02-28  *  Sales: ¥ 120 B  *  Income: ¥ 20 B  (Ratio: 17.10%)	[PL] 2012-02-29  *  Sales: ¥ 119 B  *  Income: ¥ 16 B  (Ratio: 14.05%)	[PL] 2013-02-28  *  Sales: ¥ 122 B  *  Income: ¥ 18 B  (Ratio: 15.08%)
Financial Statement Details	2010-02-28	2011-02-28	2012-02-29	2013-02-28
Sales	¥ 120 B	¥ 120 B	¥ 119 B	¥ 122 B
Cost of Sales	¥ 37 B	¥ 38 B	¥ 36 B	¥ 40 B
Gross profit	¥ 83 B	¥ 81 B	¥ 82 B	¥ 81 B
Other income	¥ 2 B	¥ 4 B	¥ 4 B	¥ 1 B
SG&A	¥ 51 B	¥ 50 B	¥ 52 B	¥ 51 B
Other expenses	¥ 14 B	¥ 14 B	¥ 17 B	¥ 13 B
Net income	¥ 20 B	¥ 20 B	¥ 16 B	¥ 18 B
Non-Consolidated :Shareowners' equity (S/S) Consolidated | Non-Consolidated | Small | Large
U-Chart(pie chart)	2010-02-28	2011-02-28	2012-02-29	2013-02-28
Issuance of new shares Dividends from surplus Net income Purchase of treasury stock Other Change in Stockholders Equity Other Change in Net Assets Net Change in Net Assets	*IN(*Right half), OUT(*Left half), BALANCE(*Net Change in Net Assets)
	[SS] 2010-02-28  *  Income: ¥ 20 B  *  Net: ¥ +9 B	[SS] 2011-02-28  *  Income: ¥ 20 B  *  Net: ¥ +14 B	[SS] 2012-02-29  *  Income: ¥ 16 B  *  Net: ¥ +8 B	[SS] 2013-02-28  *  Income: ¥ 18 B  *  Net: ¥ +14 B
Financial Statement Details	2010-02-28	2011-02-28	2012-02-29	2013-02-28
Issuance of new shares	-	-	-	-
Dividends from surplus	¥ -5 B	¥ -5 B	¥ -6 B	¥ -5 B
Net income	¥ 20 B	¥ 20 B	¥ 16 B	¥ 18 B
Purchase of treasury stock	¥ -5 B	¥ -3 M	¥ -3 B	-
Other Change in Stockholders Equity	¥ -1 M	-	¥ -1 M	¥ -1 M
Other Change in Net Assets	¥ 1 B	¥ 215 M	¥ 877 M	¥ 2 B
Net Change in Net Assets	¥ 9 B	¥ 14 B	¥ 8 B	¥ 14 B

---

Consolidated :Balance sheet (BS) Consolidated | Non-Consolidated Balance sheet | Income statement | Cash flow statement | Shareowners' equity
Consolidated :Balance sheet (Annual )	2009-02-28	2010-02-28	2011-02-28	2012-02-29	2013-02-28
Net assets	¥ 124 B	¥ 130 B	¥ 141 B	¥ 149 B	¥ 167 B
Cash and deposits	¥ 39 B	¥ 26 B	¥ 33 B	¥ 27 B	¥ 41 B
Notes and accounts receivable-trade	¥ 39 B	¥ 42 B	¥ 36 B	¥ 33 B	¥ 36 B
Short-term investment securities	¥ 4 B		¥ 5 B	¥ 7 B	¥ 12 B
Merchandise and finished goods		¥ 7 B	¥ 6 B	¥ 7 B	¥ 7 B
Raw materials and supplies		¥ 4 B	¥ 4 B	¥ 4 B	¥ 5 B
Work in process		¥ 481 M	¥ 333 M	¥ 367 M	¥ 271 M
Deferred tax assets	¥ 2 B	¥ 2 B	¥ 3 B	¥ 2 B	¥ 2 B
Allowance for doubtful accounts	¥ -217 M	¥ -267 M	¥ -241 M	¥ -202 M	¥ -211 M
Other	¥ 975 M	¥ 2 B	¥ 2 B	¥ 3 B	¥ 1 B
Current assets	¥ 95 B	¥ 86 B	¥ 92 B	¥ 87 B	¥ 107 B
Buildings and structures	¥ 33 B	¥ 39 B	¥ 39 B	¥ 40 B	¥ 40 B
Accumulated depreciation	¥ -17 B	¥ -19 B	¥ -21 B	¥ -20 B	¥ -22 B
Buildings and structures, net	¥ 15 B	¥ 20 B	¥ 18 B	¥ 19 B	¥ 17 B
Tools, furniture and fixtures	¥ 8 B	¥ 8 B	¥ 9 B	¥ 9 B	¥ 10 B
Accumulated depreciation	¥ -6 B	¥ -6 B	¥ -6 B	¥ -7 B	¥ -7 B
Tools, furniture and fixtures, net	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B
Machinery, equipment and vehicles	¥ 26 B	¥ 31 B	¥ 31 B	¥ 31 B	¥ 31 B
Accumulated depreciation	¥ -19 B	¥ -22 B	¥ -24 B	¥ -24 B	¥ -25 B
Machinery, equipment and vehicles, net	¥ 6 B	¥ 9 B	¥ 7 B	¥ 6 B	¥ 6 B
Land	¥ 11 B	¥ 12 B	¥ 12 B	¥ 12 B	¥ 12 B
Lease assets		¥ 193 M	¥ 561 M	¥ 603 M	¥ 471 M
Accumulated depreciation		¥ -15 M	¥ -107 M	¥ -213 M	¥ -326 M
Lease assets, net		¥ 177 M	¥ 454 M	¥ 390 M	¥ 145 M
Construction in progress	¥ 4 B	¥ 1 B	¥ 2 B	¥ 1 B	¥ 4 B
Property, plant and equipment	¥ 40 B	¥ 46 B	¥ 44 B	¥ 43 B	¥ 43 B
Software	¥ 19 M	¥ 117 M	¥ 85 M	¥ 345 M	¥ 291 M
Goodwill	¥ 2 B	¥ 7 B	¥ 6 B	¥ 5 B	¥ 5 B
Other	¥ 13 M	¥ 4 B	¥ 3 B	¥ 2 B	¥ 4 B
Intangible assets	¥ 4 B	¥ 15 B	¥ 12 B	¥ 16 B	¥ 17 B
Investment securities	¥ 13 B	¥ 31 B	¥ 31 B	¥ 34 B	¥ 36 B
Prepaid pension cost	¥ 5 B	¥ 4 B	¥ 4 B	¥ 3 B	¥ 3 B
Deferred tax assets	¥ 4 B	¥ 3 B	¥ 3 B	¥ 1 B	¥ 460 M
Other	¥ 1 B	¥ 2 B	¥ 2 B	¥ 2 B	¥ 3 B
Allowance for doubtful accounts	¥ -154 M	¥ -140 M	¥ -131 M	¥ -228 M	¥ -218 M
Investments and other assets	¥ 27 B	¥ 45 B	¥ 44 B	¥ 45 B	¥ 46 B
Noncurrent assets	¥ 72 B	¥ 107 B	¥ 101 B	¥ 105 B	¥ 106 B
Assets	¥ 167 B	¥ 193 B	¥ 194 B	¥ 192 B	¥ 214 B
Notes and accounts payable-trade	¥ 13 B	¥ 14 B	¥ 11 B	¥ 11 B	¥ 12 B
Lease obligations		¥ 35 M	¥ 103 M	¥ 111 M	¥ 125 M
Provision for bonuses	¥ 844 M	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B
Provision for sales returns	¥ 213 M	¥ 237 M	¥ 176 M	¥ 198 M	¥ 229 M
Accounts payable-other	¥ 9 B	¥ 8 B	¥ 7 B	¥ 6 B	¥ 7 B
Income taxes payable	¥ 8 B	¥ 4 B	¥ 10 B	¥ 3 B	¥ 6 B
Short-term loans payable	¥ 1 B	¥ 10 B	¥ 6 B	¥ 4 B	¥ 1 B
Other	¥ 704 M	¥ 2 B	¥ 2 B	¥ 2 B	¥ 4 B
Current liabilities	¥ 34 B	¥ 42 B	¥ 39 B	¥ 31 B	¥ 34 B
Long-term loans payable	¥ 881 M	¥ 8 B	¥ 3 B	¥ 1 B	¥ 989 M
Provision for retirement benefits	¥ 4 B	¥ 4 B	¥ 4 B	¥ 4 B	¥ 5 B
Provision for directors' retirement benefits	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B
Lease obligations		¥ 145 M	¥ 375 M	¥ 304 M	¥ 245 M
Deferred tax liabilities		¥ 3 B	¥ 1 B	¥ 1 B	¥ 392 M
Deferred tax liabilities for land revaluation	¥ 2 B	¥ 2 B	¥ 2 B	¥ 1 B	¥ 1 B
Other	¥ 117 M	¥ 378 M	¥ 579 M	¥ 1 B	¥ 1 B
Noncurrent liabilities	¥ 8 B	¥ 19 B	¥ 14 B	¥ 12 B	¥ 11 B
Liabilities	¥ 43 B	¥ 62 B	¥ 53 B	¥ 43 B	¥ 46 B
Capital stock	¥ 8 B	¥ 8 B	¥ 8 B	¥ 8 B	¥ 8 B
Capital surplus	¥ 8 B	¥ 8 B	¥ 8 B	¥ 8 B	¥ 8 B
Retained earnings	¥ 119 B	¥ 132 B	¥ 147 B	¥ 159 B	¥ 172 B
Treasury stock	¥ -12 B	¥ -18 B	¥ -18 B	¥ -21 B	¥ -21 B
Shareholders' equity	¥ 123 B	¥ 130 B	¥ 145 B	¥ 154 B	¥ 167 B
Valuation difference on available-for-sale securities	¥ -2 B	¥ -780 M	¥ -564 M	¥ 47 M	¥ 2 B
Revaluation reserve for land	¥ 3 B	¥ 3 B	¥ 3 B	¥ 3 B	¥ 3 B
Foreign currency translation adjustment	¥ -1 B	¥ -2 B	¥ -7 B	¥ -9 B	¥ -5 B
Valuation and translation adjustments	¥ -561 M	¥ -560 M	¥ -5 B	¥ -6 B	¥ -325 M
Minority interests	¥ 719 M	¥ 889 M	¥ 930 M	¥ 1 B	¥ 747 M
Liabilities and net assets	¥ 167 B	¥ 193 B	¥ 194 B	¥ 192 B	¥ 214 B
Long-term loans receivable	¥ 361 M	¥ 62 M
Inventories	¥ 9 B
Consolidated :Income statement (PL) Consolidated | Non-Consolidated Balance sheet | Income statement | Cash flow statement | Shareowners' equity
Consolidated :Income statement (Annual )	2009-02-28	2010-02-28	2011-02-28	2012-02-29	2013-02-28
Net sales	¥ 124 B	¥ 129 B	¥ 137 B	¥ 137 B	¥ 142 B
Operating income	¥ 32 B	¥ 28 B	¥ 28 B	¥ 25 B	¥ 25 B
Ordinary income	¥ 32 B	¥ 31 B	¥ 33 B	¥ 33 B	¥ 33 B
Net income	¥ 19 B	¥ 18 B	¥ 20 B	¥ 18 B	¥ 18 B
Comprehensive income			-	¥ 17 B	¥ 24 B
Cost of sales	¥ 39 B	¥ 42 B	¥ 47 B	¥ 46 B	¥ 51 B
Selling, general and administrative expenses	¥ 52 B	¥ 58 B	¥ 61 B	¥ 65 B	¥ 65 B
Gross profit	¥ 84 B	¥ 87 B	¥ 89 B	¥ 91 B	¥ 91 B
Interest income	¥ 237 M	¥ 96 M	¥ 59 M	¥ 71 M	¥ 67 M
Dividends income	¥ 241 M	¥ 291 M	¥ 356 M	¥ 392 M	¥ 433 M
Equity in earnings of affiliates	¥ 42 M	¥ 1 B	¥ 4 B	¥ 6 B	¥ 6 B
Foreign exchange gains				-	¥ 253 M
Royalty income	¥ 114 M	¥ 182 M	¥ 137 M	¥ 127 M	¥ 122 M
Other	¥ 685 M	¥ 445 M	¥ 357 M	¥ 402 M	¥ 383 M
Non-operating income	¥ 1 B	¥ 2 B	¥ 5 B	¥ 7 B	¥ 7 B
Interest expenses	¥ 19 M	¥ 108 M	¥ 125 M	¥ 92 M	¥ 38 M
Foreign exchange losses	¥ 1 B	¥ 58 M	¥ 131 M	¥ 44 M	-
Provision of allowance for doubtful accounts			-	¥ 97 M	-
Loss on sales of accounts receivable	¥ 53 M	¥ 29 M	¥ 23 M	¥ 21 M	¥ 24 M
Other	¥ 108 M	¥ 75 M	¥ 125 M	¥ 63 M	¥ 11 M
Non-operating expenses	¥ 1 B	¥ 272 M	¥ 406 M	¥ 319 M	¥ 74 M
Reversal of allowance for doubtful accounts	¥ 4 M	¥ 24 M	¥ 34 M	¥ 20 M	-
State subsidy		¥ 310 M	¥ 19 M	¥ 4 B	-
Insurance income			-	¥ 3 B	-
Other	¥ 94 M	¥ 87 M	¥ 39 M	¥ 34 M	¥ 1 M
Extraordinary income	¥ 1 B	¥ 1 B	¥ 3 B	¥ 8 B	¥ 501 M
Impairment loss		¥ 191 M		-	¥ 1 B
Loss on disaster			-	¥ 2 B	-
Loss on disposal of noncurrent assets	¥ 515 M	¥ 73 M	¥ 83 M	¥ 189 M	¥ 208 M
Loss on reduction of noncurrent assets	¥ 92 M	¥ 294 M	¥ 9 M	¥ 4 B	-
Loss on valuation of investment securities	¥ 1 B	¥ 181 M	¥ 138 M	¥ 1 B	-
Other	¥ 4 M		-	¥ 49 M	-
Extraordinary loss	¥ 2 B	¥ 740 M	¥ 231 M	¥ 9 B	¥ 1 B
Income before income taxes	¥ 32 B	¥ 31 B	¥ 36 B	¥ 32 B	¥ 31 B
Income taxes	¥ 13 B	¥ 13 B	¥ 14 B	¥ 13 B	¥ 13 B
Income taxes-current	¥ 14 B	¥ 12 B	¥ 17 B	¥ 12 B	¥ 13 B
Income taxes-deferred	¥ -1 B	¥ 426 M	¥ -2 B	¥ 1 B	¥ -518 M
Income before minority interests			-	¥ 18 B	¥ 18 B
Minority interests in income	¥ 67 M	¥ 139 M	¥ 173 M	¥ 184 M	¥ -227 M
Valuation difference on available-for-sale securities			-	¥ 607 M	¥ 2 B
Foreign currency translation adjustment			-	¥ -1 B	¥ 3 B
Share of other comprehensive income of associates accounted for using equity method			-	¥ -534 M	¥ 1 B
Other comprehensive income			-	¥ -1 B	¥ 6 B
Comprehensive income attributable to owners of the parent			-	¥ 17 B	¥ 24 B
Comprehensive income attributable to minority interests			-	¥ 171 M	¥ -219 M
Gain on disposal of noncurrent assets			¥ 7 M	-
Gain on liquidation of subsidiaries and affiliates	¥ 53 M
Reversal of provision for retirement benefits	¥ 701 M
Loss on sales of investment securities
Consolidated :Cash flow statement (CF) Consolidated | Non-Consolidated Balance sheet | Income statement | Cash flow statement | Shareowners' equity
Consolidated :Cash flow statement (Annual )	2009-02-28	2010-02-28	2011-02-28	2012-02-29	2013-02-28
Subtotal	¥ 34 B	¥ 34 B	¥ 42 B	¥ 34 B	¥ 34 B
Depreciation and amortization	¥ 4 B	¥ 5 B	¥ 6 B	¥ 6 B	¥ 6 B
Impairment loss		¥ 191 M		-	¥ 1 B
Amortization of goodwill	¥ 2 B	¥ 2 B	¥ 779 M	¥ 711 M	¥ 715 M
Increase (decrease) in allowance for doubtful accounts	¥ 41 M	¥ 34 M	¥ -29 M	¥ 59 M	¥ -2 M
Interest and dividends income	¥ -478 M	¥ -388 M	¥ -415 M	¥ -464 M	¥ -500 M
Interest expenses	¥ 19 M	¥ 108 M	¥ 125 M	¥ 92 M	¥ 38 M
Foreign exchange losses (gains)	¥ 23 M	¥ 15 M	¥ 71 M	¥ 2 M	¥ -83 M
Equity in (earnings) losses of affiliates	¥ -42 M	¥ -1 B	¥ -4 B	¥ -6 B	¥ -6 B
Decrease (increase) in notes and accounts receivable-trade	¥ -8 B	¥ -1 B	¥ 5 B	¥ 2 B	¥ -3 B
Decrease (increase) in inventories	¥ -784 M	¥ -1 B	¥ 702 M	¥ -2 B	¥ -754 M
Increase (decrease) in notes and accounts payable-trade	¥ 3 B	¥ 857 M	¥ -3 B	¥ 790 M	¥ 792 M
Loss (gain) on sales of investment securities		¥ -87 M	¥ -39 M	¥ -34 M	¥ -1 M
Increase (decrease) in provision for bonuses	¥ 35 M	¥ 74 M	¥ 185 M	¥ 79 M	¥ 87 M
Increase (decrease) in provision for directors' retirement benefits	¥ 70 M	¥ 2 M	¥ 26 M	¥ 29 M	¥ 72 M
Increase (decrease) in provision for retirement benefits	¥ 505 M	¥ 154 M	¥ 198 M	¥ 21 M	¥ 188 M
Increase (decrease) in provision for sales returns	¥ 56 M	¥ 24 M	¥ -61 M	¥ 22 M	¥ 30 M
Loss (gain) on valuation of investment securities	¥ 1 B	¥ 181 M	¥ 138 M	¥ 1 B	-
Loss (gain) on disposal of noncurrent assets	¥ 515 M	¥ 73 M	¥ 83 M	¥ 189 M	¥ 208 M
Loss on reduction of noncurrent assets			-	¥ 4 B	-
Insurance income			-	¥ -3 B	-
Subsidy income		¥ -310 M	¥ -19 M	¥ -4 B	-
Decrease (increase) in other current assets	¥ -105 M	¥ -280 M	¥ -568 M	¥ -1 B	¥ 621 M
Increase (decrease) in other current liabilities	¥ 693 M	¥ -2 B	¥ 494 M	¥ -1 B	¥ 1 B
Other, net	¥ -1 B	¥ 604 M	¥ 742 M	¥ 1 B	¥ 412 M
Interest and dividends income received	¥ 758 M	¥ 2 B	¥ 5 B	¥ 6 B	¥ 8 B
Interest expenses paid	¥ -19 M	¥ -108 M	¥ -125 M	¥ -92 M	¥ -38 M
Income taxes paid	¥ -12 B	¥ -16 B	¥ -11 B	¥ -18 B	¥ -9 B
Proceeds from insurance income			-	¥ 3 B	-
Payments for loss on disaster			-	¥ -793 M	-
Net cash provided by (used in) operating activities	¥ 22 B	¥ 20 B	¥ 36 B	¥ 25 B	¥ 32 B
Decrease (increase) in short-term investment securities				-	¥ -967 M
Purchase of property, plant and equipment	¥ -4 B	¥ -6 B	¥ -5 B	¥ -9 B	¥ -4 B
Proceeds from sales of property, plant and equipment	¥ 20 M		¥ 37 M	¥ 3 M	¥ 5 M
Purchase of investment securities	¥ -4 B	¥ -2 B	¥ -2 B	¥ -3 B	¥ -1 B
Payments of loans receivable	¥ -17 M		¥ -9 M	¥ -11 M	-
Collection of loans receivable	¥ 206 M	¥ 112 M	¥ 216 M	¥ 13 M	¥ 44 M
Proceeds from sales and redemption of investment securities	¥ 65 M	¥ 222 M	¥ 189 M	¥ 234 M	¥ 3 M
Purchase of intangible assets	¥ -1 B	¥ -201 M	¥ -217 M	¥ -5 B	¥ -659 M
Decrease (increase) in time deposits	¥ -2 B	¥ 6 B	¥ -259 M	¥ 189 M	¥ -134 M
Net cash provided by (used in) investing activities	¥ -15 B	¥ -32 B	¥ -8 B	¥ -15 B	¥ -7 B
Proceeds from long-term loans payable	¥ 245 M	¥ 15 B	¥ 270 M	¥ 1 B	-
Repayment of long-term loans payable	¥ -279 M	¥ -2 B	¥ -5 B	¥ -5 B	¥ -2 B
Purchase of treasury stock	¥ -66 M	¥ -5 B	¥ -3 M	¥ -3 B	-
Cash dividends paid	¥ -5 B	¥ -5 B	¥ -5 B	¥ -6 B	¥ -6 B
Increase (decrease) in short-term loans payable	¥ 124 M	¥ 4 B	¥ -4 B	¥ 881 M	¥ -211 M
Cash dividends paid to minority shareholders	¥ -48 M	¥ -37 M	¥ -114 M	¥ -65 M	¥ -69 M
Other, net	¥ -9 M	¥ -45 M	¥ -67 M	¥ -140 M	¥ -202 M
Net cash provided by (used in) financing activities	¥ -5 B	¥ 4 B	¥ -15 B	¥ -13 B	¥ -9 B
Effect of exchange rate change on cash and cash equivalents	¥ -337 M	¥ 25 M	¥ -1 B	¥ -506 M	¥ 1 B
Net increase (decrease) in cash and cash equivalents	¥ 650 M	¥ -7 B	¥ 11 B	¥ -3 B	¥ 16 B
Cash and cash equivalents	¥ 33 B	¥ 26 B	¥ 37 B	¥ 34 B	¥ 50 B
Proceeds from stock issuance to minority shareholders			¥ 2 M	-
Purchase of short-term investment securities	¥ -10 B	¥ -3 B
Proceeds from sales and redemption of securities	¥ 9 B	¥ 6 B
Purchase of investments in subsidiaries resulting in change in scope of consolidation		¥ -32 B
Other, net	¥ 92 M	¥ -9 M
Consolidated :Shareowners' equity (SS) Consolidated | Non-Consolidated Balance sheet | Income statement | Cash flow statement | Shareowners' equity
Consolidated :Shareowners' equity (Annual )	2009-02-28	2010-02-28	2011-02-28	2012-02-29	2013-02-28
Total changes of items during the period				-	-
Total changes of items during the period				-	-
Dividends from surplus	¥ -5 B	¥ -5 B	¥ -5 B	¥ -6 B	¥ -5 B
Total changes of items during the period	¥ 13 B	¥ 12 B	¥ 14 B	¥ 12 B	¥ 12 B
Purchase of treasury stock	¥ -67 M	¥ -5 B	¥ -4 M	¥ -3 B	¥ -1 M
Total changes of items during the period	¥ -67 M	¥ -5 B	¥ -4 M	¥ -3 B	¥ -1 M
Dividends from surplus	¥ -5 B	¥ -5 B	¥ -5 B	¥ -6 B	¥ -5 B
Net income	¥ 19 B	¥ 18 B	¥ 20 B	¥ 18 B	¥ 18 B
Purchase of treasury stock	¥ -67 M	¥ -5 B	¥ -4 M	¥ -3 B	¥ -1 M
Total changes of items during the period	¥ 13 B	¥ 6 B	¥ 14 B	¥ 9 B	¥ 12 B
Net changes of items other than shareholders' equity	¥ -2 B	¥ 1 B	¥ 215 M	¥ 611 M	¥ 2 B
Total changes of items during the period	¥ -2 B	¥ 1 B	¥ 215 M	¥ 611 M	¥ 2 B
Net changes of items other than shareholders' equity				¥ 270 M	-
Total changes of items during the period				¥ 270 M	-
Net changes of items other than shareholders' equity	¥ -883 M	¥ -1 B	¥ -4 B	¥ -2 B	¥ 4 B
Total changes of items during the period	¥ -883 M	¥ -1 B	¥ -4 B	¥ -2 B	¥ 4 B
Net changes of items other than shareholders' equity	¥ -3 B	¥ 1 M	¥ -4 B	¥ -1 B	¥ 6 B
Total changes of items during the period	¥ -3 B	¥ 1 M	¥ -4 B	¥ -1 B	¥ 6 B
Net changes of items other than shareholders' equity	¥ -31 M	¥ 170 M	¥ 40 M	¥ 106 M	¥ -289 M
Total changes of items during the period	¥ -31 M	¥ 170 M	¥ 40 M	¥ 106 M	¥ -289 M
Dividends from surplus	¥ -5 B	¥ -5 B	¥ -5 B	¥ -6 B	¥ -5 B
Net income	¥ 19 B	¥ 18 B	¥ 20 B	¥ 18 B	¥ 18 B
Purchase of treasury stock	¥ -67 M	¥ -5 B	¥ -4 M	¥ -3 B	¥ -1 M
Net changes of items other than shareholders' equity	¥ -3 B	¥ 171 M	¥ -4 B	¥ -1 B	¥ 5 B
Total changes of items during the period	¥ 10 B	¥ 6 B	¥ 10 B	¥ 8 B	¥ 18 B
Reversal of revaluation reserve for land			-	-
Reversal of revaluation reserve for land			-	-
Reversal of revaluation reserve for land			-	-

Non-Consolidated :Balance sheet (BS) Consolidated | Non-Consolidated Balance sheet | Income statement | Shareowners' equity
Non-Consolidated :Balance sheet (Annual )	2009-02-28	2010-02-28	2011-02-28	2012-02-29	2013-02-28
Net assets	¥ 120 B	¥ 130 B	¥ 145 B	¥ 153 B	¥ 168 B
Cash and deposits	¥ 36 B	¥ 17 B	¥ 24 B	¥ 20 B	¥ 34 B
Notes receivable-trade	¥ 329 M	¥ 422 M	¥ 365 M	¥ 621 M	¥ 436 M
Accounts receivable-trade	¥ 38 B	¥ 39 B	¥ 34 B	¥ 31 B	¥ 34 B
Short-term investment securities	¥ 4 B		¥ 2 B	¥ 2 B	-
Merchandise and finished goods		¥ 6 B	¥ 5 B	¥ 5 B	¥ 6 B
Raw materials and supplies		¥ 3 B	¥ 3 B	¥ 3 B	¥ 3 B
Work in process	¥ 326 M	¥ 291 M	¥ 137 M	¥ 169 M	¥ 104 M
Prepaid expenses	¥ 224 M	¥ 253 M	¥ 229 M	¥ 168 M	¥ 196 M
Deferred tax assets	¥ 2 B	¥ 1 B	¥ 2 B	¥ 2 B	¥ 1 B
Allowance for doubtful accounts	¥ -208 M	¥ -213 M	¥ -191 M	¥ -178 M	¥ -193 M
Other	¥ 519 M	¥ 614 M	¥ 693 M	¥ 885 M	¥ 680 M
Current assets	¥ 91 B	¥ 69 B	¥ 74 B	¥ 66 B	¥ 81 B
Buildings	¥ 25 B	¥ 28 B	¥ 28 B	¥ 27 B	¥ 27 B
Accumulated depreciation	¥ -14 B	¥ -15 B	¥ -16 B	¥ -15 B	¥ -16 B
Buildings, net	¥ 11 B	¥ 12 B	¥ 11 B	¥ 11 B	¥ 10 B
Structures	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B
Accumulated depreciation	¥ -1 B	¥ -1 B	¥ -1 B	¥ -1 B	¥ -1 B
Structures, net	¥ 578 M	¥ 588 M	¥ 620 M	¥ 547 M	¥ 470 M
Machinery and equipment	¥ 24 B	¥ 28 B	¥ 28 B	¥ 26 B	¥ 27 B
Accumulated depreciation	¥ -18 B	¥ -20 B	¥ -22 B	¥ -22 B	¥ -22 B
Machinery and equipment, net	¥ 5 B	¥ 7 B	¥ 5 B	¥ 4 B	¥ 4 B
Vehicles	¥ 193 M	¥ 211 M	¥ 240 M	¥ 253 M	¥ 247 M
Accumulated depreciation	¥ -171 M	¥ -176 M	¥ -198 M	¥ -222 M	¥ -229 M
Vehicles, net	¥ 22 M	¥ 35 M	¥ 41 M	¥ 30 M	¥ 18 M
Tools, furniture and fixtures	¥ 7 B	¥ 8 B	¥ 8 B	¥ 8 B	¥ 8 B
Accumulated depreciation	¥ -5 B	¥ -6 B	¥ -6 B	¥ -6 B	¥ -7 B
Tools, furniture and fixtures, net	¥ 2 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B
Land	¥ 10 B	¥ 10 B	¥ 10 B	¥ 10 B	¥ 10 B
Lease assets		¥ 77 M	¥ 77 M	¥ 77 M	¥ 85 M
Accumulated depreciation		¥ -7 M	¥ -21 M	¥ -36 M	¥ -51 M
Lease assets, net		¥ 69 M	¥ 55 M	¥ 40 M	¥ 34 M
Construction in progress	¥ 4 B	¥ 1 B	¥ 2 B	¥ 1 B	¥ 2 B
Property, plant and equipment	¥ 35 B	¥ 35 B	¥ 33 B	¥ 30 B	¥ 30 B
Other	¥ 11 M	¥ 11 M	¥ 11 M	¥ 10 M	¥ 10 M
Intangible assets	¥ 4 B	¥ 2 B	¥ 2 B	¥ 7 B	¥ 6 B
Investment securities	¥ 12 B	¥ 14 B	¥ 17 B	¥ 19 B	¥ 23 B
Stocks of subsidiaries and affiliates	¥ 1 B	¥ 44 B	¥ 44 B	¥ 46 B	¥ 45 B
Investments in capital	¥ 16 M	¥ 15 M	¥ 15 M	¥ 15 M	¥ 14 M
Investments in capital of subsidiaries and affiliates	¥ 1 B	¥ 1 B	¥ 2 B	¥ 2 B	¥ 2 B
Long-term loans receivable from subsidiaries and affiliates	¥ 409 M	¥ 325 M	¥ 219 M	¥ 818 M	¥ 1 B
Long-term loans receivable from employees	¥ 173 M	¥ 148 M	¥ 127 M	¥ 123 M	¥ 81 M
Claims provable in bankruptcy, claims provable in rehabilitation and other	¥ 203 M	¥ 180 M	¥ 180 M	¥ 180 M	¥ 180 M
Long-term prepaid expenses	¥ 360 M	¥ 251 M	¥ 94 M	¥ 46 M	¥ 44 M
Prepaid pension cost	¥ 5 B	¥ 4 B	¥ 4 B	¥ 3 B	¥ 3 B
Deferred tax assets	¥ 4 B	¥ 3 B	¥ 3 B	¥ 1 B	¥ 783 M
Membership	¥ 228 M	¥ 228 M	¥ 228 M	¥ 270 M	¥ 249 M
Business insurance funds	¥ 657 M	¥ 855 M	¥ 1 B	¥ 1 B	¥ 1 B
Other	¥ 2 B	¥ 777 M	¥ 584 M	¥ 593 M	¥ 1 B
Allowance for doubtful accounts	¥ -525 M	¥ -368 M	¥ -349 M	¥ -425 M	¥ -419 M
Investments and other assets	¥ 28 B	¥ 73 B	¥ 77 B	¥ 78 B	¥ 81 B
Noncurrent assets	¥ 68 B	¥ 111 B	¥ 112 B	¥ 117 B	¥ 119 B
Assets	¥ 160 B	¥ 180 B	¥ 187 B	¥ 184 B	¥ 200 B
Accounts payable-trade	¥ 11 B	¥ 11 B	¥ 8 B	¥ 8 B	¥ 9 B
Accrued expenses	¥ 215 M	¥ 191 M	¥ 204 M	¥ 219 M	¥ 218 M
Lease obligations		¥ 14 M	¥ 15 M	¥ 14 M	¥ 16 M
Provision for bonuses	¥ 811 M	¥ 847 M	¥ 880 M	¥ 892 M	¥ 916 M
Provision for sales returns	¥ 213 M	¥ 237 M	¥ 176 M	¥ 198 M	¥ 229 M
Accounts payable-other	¥ 10 B	¥ 7 B	¥ 7 B	¥ 6 B	¥ 7 B
Income taxes payable	¥ 8 B	¥ 4 B	¥ 9 B	¥ 3 B	¥ 6 B
Deposits received	¥ 61 M	¥ 63 M	¥ 71 M	¥ 77 M	¥ 89 M
Short-term loans payable		¥ 9 B	¥ 5 B	¥ 2 B	-
Other	¥ 132 M	¥ 36 M	¥ 39 M	¥ 34 M	¥ 30 M
Current liabilities	¥ 31 B	¥ 34 B	¥ 31 B	¥ 22 B	¥ 24 B
Provision for retirement benefits	¥ 4 B	¥ 4 B	¥ 4 B	¥ 4 B	¥ 4 B
Provision for directors' retirement benefits	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B	¥ 1 B
Lease obligations		¥ 55 M	¥ 41 M	¥ 26 M	¥ 19 M
Deferred tax liabilities for land revaluation	¥ 2 B	¥ 2 B	¥ 2 B	¥ 1 B	¥ 1 B
Other	¥ 22 M	¥ 20 M	¥ 1 M	¥ 2 M	¥ 2 M
Noncurrent liabilities	¥ 7 B	¥ 15 B	¥ 10 B	¥ 7 B	¥ 8 B
Liabilities	¥ 39 B	¥ 49 B	¥ 41 B	¥ 30 B	¥ 32 B
Capital stock	¥ 8 B	¥ 8 B	¥ 8 B	¥ 8 B	¥ 8 B
Legal capital surplus	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B	¥ 2 B
Other capital surplus	¥ 6 B	¥ 6 B	¥ 6 B	¥ 6 B	¥ 6 B
Capital surplus	¥ 8 B	¥ 8 B	¥ 8 B	¥ 8 B	¥ 8 B
General reserve	¥ 94 B	¥ 104 B	¥ 120 B	¥ 135 B	¥ 146 B
Retained earnings brought forward	¥ 21 B	¥ 26 B	¥ 24 B	¥ 20 B	¥ 21 B
Retained earnings	¥ 115 B	¥ 130 B	¥ 144 B	¥ 155 B	¥ 167 B
Treasury stock	¥ -12 B	¥ -18 B	¥ -18 B	¥ -21 B	¥ -21 B
Shareholders' equity	¥ 119 B	¥ 128 B	¥ 142 B	¥ 150 B	¥ 162 B
Valuation difference on available-for-sale securities	¥ -2 B	¥ -810 M	¥ -595 M	¥ 11 M	¥ 2 B
Revaluation reserve for land	¥ 3 B	¥ 3 B	¥ 3 B	¥ 3 B	¥ 3 B
Valuation and translation adjustments	¥ 1 B	¥ 2 B	¥ 2 B	¥ 3 B	¥ 5 B
Liabilities and net assets	¥ 160 B	¥ 180 B	¥ 187 B	¥ 184 B	¥ 200 B
Long-term loans payable		¥ 7 B	¥ 2 B	-
Short-term loans receivable from subsidiaries and affiliates	¥ 147 M	¥ 190 M
Software	¥ 12 M	¥ 2 M
Allowance for investment loss	¥ -263 M	¥ -109 M
Merchandise	¥ 686 M
Finished goods	¥ 4 B
Raw materials	¥ 1 B
Supplies	¥ 1 B
Goodwill	¥ 2 B
Provision for loss on guarantees	¥ 210 M
Non-Consolidated :Income statement (PL) Consolidated | Non-Consolidated Balance sheet | Income statement | Shareowners' equity
Non-Consolidated :Income statement (Annual )	2009-02-28	2010-02-28	2011-02-28	2012-02-29	2013-02-28
Net sales	¥ 118 B	¥ 120 B	¥ 120 B	¥ 119 B	¥ 122 B
Operating income	¥ 31 B	¥ 31 B	¥ 30 B	¥ 29 B	¥ 30 B
Ordinary income	¥ 32 B	¥ 32 B	¥ 31 B	¥ 30 B	¥ 30 B
Net income	¥ 19 B	¥ 20 B	¥ 20 B	¥ 16 B	¥ 18 B
Net sales of goods	¥ 7 B	¥ 8 B	¥ 7 B	¥ 5 B	¥ 6 B
Net sales of finished goods	¥ 110 B	¥ 112 B	¥ 112 B	¥ 113 B	¥ 115 B
Cost of sales	¥ 36 B	¥ 37 B	¥ 38 B	¥ 36 B	¥ 40 B
Beginning goods	¥ 899 M	¥ 686 M	¥ 862 M	¥ 655 M	¥ 723 M
Cost of purchased goods	¥ 3 B	¥ 4 B	¥ 4 B	¥ 3 B	¥ 5 B
Ending goods	¥ 686 M	¥ 862 M	¥ 655 M	¥ 723 M	¥ 1 B
Total			¥ 45 B	¥ 45 B	¥ 47 B
Beginning finished goods	¥ 4 B	¥ 4 B	¥ 5 B	¥ 4 B	¥ 4 B
Cost of products manufactured	¥ 34 B	¥ 34 B	¥ 34 B	¥ 36 B	¥ 36 B
Ending finished goods	¥ 4 B	¥ 5 B	¥ 4 B	¥ 4 B	¥ 4 B
Transfer to other account	¥ 535 M	¥ 982 M	¥ 1 B	¥ 2 B	¥ 714 M
Selling, general and administrative expenses	¥ 49 B	¥ 51 B	¥ 50 B	¥ 52 B	¥ 51 B
Gross profit	¥ 81 B	¥ 83 B	¥ 81 B	¥ 82 B	¥ 81 B
Gross profit-net	¥ 81 B	¥ 83 B	¥ 81 B	¥ 82 B	¥ 81 B
Provision for sales returns				¥ 22 M	¥ 30 M
Interest income	¥ 166 M	¥ 50 M	¥ 21 M	¥ 19 M	¥ 22 M
Interest on securities	¥ 19 M	¥ 10 M	¥ 1 M	-	-
Dividends income	¥ 595 M	¥ 356 M	¥ 477 M	¥ 457 M	¥ 499 M
Foreign exchange gains				-	¥ 190 M
Royalty income	¥ 151 M	¥ 213 M	¥ 166 M	¥ 160 M	¥ 162 M
Real estate rent	¥ 103 M	¥ 94 M	¥ 43 M	¥ 48 M	¥ 46 M
Other	¥ 391 M	¥ 145 M	¥ 151 M	¥ 166 M	¥ 113 M
Non-operating income	¥ 1 B	¥ 880 M	¥ 861 M	¥ 854 M	¥ 1 B
Interest expenses		¥ 86 M	¥ 102 M	¥ 53 M	¥ 9 M
Foreign exchange losses	¥ 1 B	¥ 72 M	¥ 87 M	¥ 28 M	-
Provision of allowance for doubtful accounts		¥ 3 M		¥ 97 M	¥ 4 M
Loss on sales of accounts receivable	¥ 53 M	¥ 29 M	¥ 23 M	¥ 21 M	¥ 24 M
Other	¥ 34 M	¥ 13 M	¥ 1 M	¥ 6 M	¥ 3 M
Non-operating expenses	¥ 1 B	¥ 205 M	¥ 215 M	¥ 206 M	¥ 41 M
Gain on sales of investment securities	¥ 1 M	¥ 87 M	¥ 39 M	¥ 34 M	¥ 1 M
Reversal of allowance for doubtful accounts	¥ 220 M	¥ 160 M	¥ 48 M	¥ 34 M	-
Insurance income			-	¥ 3 B	-
Extraordinary income	¥ 1 B	¥ 1 B	¥ 3 B	¥ 3 B	¥ 501 M
Loss on disaster			-	¥ 2 B	-
Loss on disposal of noncurrent assets	¥ 495 M	¥ 57 M	¥ 37 M	¥ 123 M	¥ 141 M
Loss on valuation of investment securities	¥ 1 B	¥ 181 M	¥ 117 M	¥ 1 B	-
Loss on valuation of stocks of subsidiaries and affiliates			-	¥ 47 M	¥ 573 M
Extraordinary loss	¥ 2 B	¥ 595 M	¥ 154 M	¥ 4 B	¥ 715 M
Income before income taxes	¥ 32 B	¥ 33 B	¥ 34 B	¥ 29 B	¥ 30 B
Income taxes	¥ 12 B	¥ 13 B	¥ 13 B	¥ 12 B	¥ 12 B
Income taxes-current	¥ 14 B	¥ 12 B	¥ 15 B	¥ 11 B	¥ 11 B
Income taxes-deferred	¥ -1 B	¥ 942 M	¥ -1 B	¥ 1 B	¥ 541 M
Reversal of provision for sales returns	¥ -56 M	¥ -24 M	¥ 61 M	¥ -22 M
Gain on disposal of noncurrent assets			¥ 6 M	-
Reversal of allowance for investment loss		¥ 153 M	¥ 109 M	-
Total		¥ 44 B	¥ 45 B
Gain on investment of securities	¥ 10 M	¥ 8 M
Reversal of provision for loss on guarantees		¥ 210 M
State subsidy		¥ 180 M
Impairment loss		¥ 191 M
Loss on reduction of noncurrent assets		¥ 165 M
Total	¥ 42 B	¥ 44 B
Gain on liquidation of subsidiaries and affiliates	¥ 53 M
Reversal of provision for retirement benefits	¥ 701 M
Loss on sales of investment securities
Provision of allowance for investment loss	¥ 79 M
Loss on valuation of membership	¥ 4 M
Provision for loss on guarantees	¥ 13 M
Non-Consolidated :Shareowners' equity (SS) Consolidated | Non-Consolidated Balance sheet | Income statement | Shareowners' equity
Non-Consolidated :Shareowners' equity (Annual )	2009-02-28	2010-02-28	2011-02-28	2012-02-29	2013-02-28
Total changes of items during the period				-	-
Total changes of items during the period				-	-
Total changes of items during the period				-	-
Total changes of items during the period				-	-
Provision of general reserve	¥ 12 B	¥ 10 B	¥ 16 B	¥ 15 B	¥ 11 B
Total changes of items during the period	¥ 12 B	¥ 10 B	¥ 16 B	¥ 15 B	¥ 11 B
Dividends from surplus	¥ -5 B	¥ -5 B	¥ -5 B	¥ -6 B	¥ -5 B
Provision of general reserve	¥ -12 B	¥ -10 B	¥ -16 B	¥ -15 B	¥ -11 B
Total changes of items during the period	¥ 1 B	¥ 4 B	¥ -1 B	¥ -4 B	¥ 1 B
Dividends from surplus	¥ -5 B	¥ -5 B	¥ -5 B	¥ -6 B	¥ -5 B
Net income	¥ 19 B	¥ 20 B	¥ 20 B	¥ 16 B	¥ 18 B
Provision of general reserve				-	-
Total changes of items during the period	¥ 13 B	¥ 14 B	¥ 14 B	¥ 10 B	¥ 12 B
Purchase of treasury stock	¥ -66 M	¥ -5 B	¥ -3 M	¥ -3 B	-
Total changes of items during the period	¥ -66 M	¥ -5 B	¥ -3 M	¥ -3 B	-
Dividends from surplus	¥ -5 B	¥ -5 B	¥ -5 B	¥ -6 B	¥ -5 B
Net income	¥ 19 B	¥ 20 B	¥ 20 B	¥ 16 B	¥ 18 B
Purchase of treasury stock	¥ -66 M	¥ -5 B	¥ -3 M	¥ -3 B	-
Total changes of items during the period	¥ 13 B	¥ 8 B	¥ 14 B	¥ 7 B	¥ 12 B
Net changes of items other than shareholders' equity	¥ -2 B	¥ 1 B	¥ 214 M	¥ 607 M	¥ 2 B
Total changes of items during the period	¥ -2 B	¥ 1 B	¥ 214 M	¥ 607 M	¥ 2 B
Net changes of items other than shareholders' equity				¥ 270 M	-
Total changes of items during the period				¥ 270 M	-
Net changes of items other than shareholders' equity	¥ -2 B	¥ 1 B	¥ 215 M	¥ 877 M	¥ 2 B
Total changes of items during the period	¥ -2 B	¥ 1 B	¥ 215 M	¥ 877 M	¥ 2 B
Dividends from surplus	¥ -5 B	¥ -5 B	¥ -5 B	¥ -6 B	¥ -5 B
Net income	¥ 19 B	¥ 20 B	¥ 20 B	¥ 16 B	¥ 18 B
Purchase of treasury stock	¥ -66 M	¥ -5 B	¥ -3 M	¥ -3 B	-
Net changes of items other than shareholders' equity	¥ -2 B	¥ 1 B	¥ 215 M	¥ 877 M	¥ 2 B
Total changes of items during the period	¥ 11 B	¥ 9 B	¥ 14 B	¥ 8 B	¥ 14 B
Reversal of revaluation reserve for land			-	-
Reversal of revaluation reserve for land			-	-
Reversal of revaluation reserve for land			-	-
Reversal of revaluation reserve for land			-	-

Free Download

*Free Download Financial Statement dataMember limited service.

[Data] Balance sheet, Income statement, Cash flow statement, Shareowners' equity (*Consolidated or Non-Consolidated. two or more terms)

Sponsored Link

Related Information: HISAMITSU PHARMACEUTICAL (Annual )

Statement Type

Annual : HISAMITSU PHARMACEUTICAL

First quarter : HISAMITSU PHARMACEUTICAL

Second quarter : HISAMITSU PHARMACEUTICAL

Third quarter : HISAMITSU PHARMACEUTICAL

Analysis Menu

Outline : HISAMITSU PHARMACEUTICAL

Statement : HISAMITSU PHARMACEUTICAL

Rating : HISAMITSU PHARMACEUTICAL

Indicator : HISAMITSU PHARMACEUTICAL

Download : HISAMITSU PHARMACEUTICAL

Industry Comparison Ranking

Chemicals - EDIUNET Industry Rankings

Chemicals - EDIUNET Credit Rating

Chemicals - EDIUNET Industry Avg

Comparison with a neighboring company

Saga - EDIUNET Prefectures

Saga鳥栖市 - EDIUNET Prefectures

Related company's newest statement

Date	Company	Credit Rating	Date
1/23	Milbon	AA→AAA	2013-12-20
1/17	Kawaguchi Chemical Indu..	BBB→BB	2013-11-30
1/17	SANKEI CHEMICAL	A	2013-11-30
1/15	HOKKO CHEMICAL INDUSTRY	BB→B	2013-11-30
1/15	Daito Pharmaceutical Co .	AA	2013-11-30 (Q2)
1/15	KAWAKAMI PAINT MFG.	B→BB	2013-11-30
1/15	旭化学工業	AA	2013-11-30 (Q1)
1/10	OSAKA ORGANIC CHEMICAL ..	BB→BBB	2013-11-30
1/10	HISAMITSU PHARMACEUTICAL	A	2013-11-30 (Q3)
1/10	AMS Life Science	BBB→BB	2013-11-30 (Q1)

EDIUNET Investment News (Chemicals)

1/23 Chemicals (Milbon:AA→AAA)

1/17 Chemicals (Kawaguchi Chemica..

1/15 Chemicals (HOKKO CHEMICAL IN..

1/10 Chemicals (OSAKA ORGANIC CHE..

1/9 Chemicals (SANKO GOSEI:A)

12/27 Chemicals (Niitaka:A)

12/18 Chemicals (KUMIAI CHEMICAL I..

12/12 Chemicals (IHARA CHEMICAL IN..

12/11 Chemicals (Konoshima Chemica..

12/10 Chemicals (NATOCO:AA)

Company Information

Ticker	Market	Industry	Month	report	Rating
HISAMITSU PHARMACEUTICAL	4530	TSE 1st	Chemicals	2	Annual	A

Related Company

ダイセル (Sales ¥ 358 B)

Fuso Pharmaceutical Industries (Sales ¥ 48 B)

NIPPON PAINT (Sales ¥ 233 B)

持田製薬 (Sales ¥ 89 B)

Otsuka Holdings (Sales ¥ 1.2 T)

富士製薬工業 (Sales ¥ 25 B)

Shin-Etsu Chemical (Sales ¥ 1.0 T)

中外製薬 (Sales ¥ 391 B)

JSR (Sales ¥ 371 B)

エスケー化研 (Sales ¥ 82 B)

大正製薬ホールディングス (Sales ¥ 285 B)

HISAMITSU PHARMACEUTICAL (Sales ¥ 142 B)

TSUMURA & CO. (Sales ¥ 105 B)

関連する株式投資情報

EDIUNET Caution

*Financial data might be different from the actual one. Please confirm the original, and read Caution.

*This site has obtained the information from the FSA's EDINET, Tokyo Stock Exchange's TDnet and Pay statistical data services, Fukuoka stock Exchange's Stock market capitalization, Center for Spatial Information Science's CSV Geocoding Service. The copyright of the information belongs to each corporation etc. .